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Introduction
While gallbladder cancer (GBC) has an extremely poor prognosis, recent advances introducing extended surgical therapy combining liver resection with wide lymph node dissection is beginning to improve the long-term survival of patients with GBC [1, 2] .
Using this methodology, Tsukada et al. achieved excellent 5-year survival rates in patients with stage I and II tumors. The 5-year survival rate, however, is highly reduced to less than 5% when noncurative resections involving distant metastasis were performed [3] . To understand the molecular basis of GBC, we previously investigated a novel tumor-associated antigen found in GBC; Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) correlated significantly with tumor progression, predicting a poor outcome in gallbladder cancer [4] . In this study, we examined a rare case of long-term disease-free survival in a patient with a solitary metastatic lung tumor derived from GBC.
We identified the lung tumor as a metastasis by immunostaining with anti-thyroid transcription factor 1 (TTF-1) antibodies. To investigate the characteristics of the primary gallbladder and metastatic lung cancer cells, we also examined the expression of RCAS1 and infiltration of CD8 + T cells.
Case report
In 
Pathological Examination
Macroscopically, we discovered a soft papillary tumor within the body of the gallbladder ( Figure 3A ). In the specimen from the right lung, we observed a white nodular tumor ( Figure 3B ). Upon microscopic examination, the papillary adenocarcinoma appeared to infiltrate the gallbladder sub-serosa. Vascular or lymphatic tumor involvement was apparent, but no lymph node metastasis could be observed ( Figure 4A ). In the right lung specimen, the adenocarcinoma, appearing similar to the primary gallbladder tumor, demonstrated significant necrosis ( Figure 4B ).
Methods

Immunohistochemistry
Paraffin-embedded, formalin-fixed tissue blocks were sectioned at 4 μm, heated at 60ºC for 30 minutes, deparaffinized, and hydrated using a xylene and alcohol series.
Optimum pretreatment and dilutions were determined by testing known positive and negative control materials. We utilized the following mouse monoclonal primary antibodies for staining: anti-human TTF-1 (Dako; clone 8G7G3-1; dilution 1:150), anti-human CD8 (Dako; clone C8/144b; dilution 1: 100), and anti-human 22-1-1 (Medical & Biological Laboratories, Tokyo, Japan; dilution 1:500).
Evaluation of immunostaining
For TTF-1, tumors demonstrating cytoplasmic immunoreactivity were selected for further analysis by grading the intensity of the stain. Tumors were characterized as 3+ when positive staining could be observed upon examination of the slide with the 4 objective, 2+
when positivity was seen using the 10 objective, 1+ when staining could be seen only at a magnification of 40, and 0 if no staining could be observed even when using the 40 objective. Samples were also divided into categories based on the percentage of positive cells, with groups of more than 50% positive tumor cells, between 10% and 50%, less than 10%, and no cells [5] .
The number of immunoreactive CD8 + T cells detected within the cancer cell nests were quantified with a microscopic field of ´200 (0.933 mm 2 ). Five areas with most abundant infiltration were selected, and the average numbers of 0, 1-9, 10-29, and over 30
were scored as group 0, I, II, and III, respectively. Group I, II, and III were considered positive patterns, while group 0 was considered negative [6] .
The evaluation of the degree of RCAS1 immunoreactivity was performed as described by Oshikiri et al. [4] , classifying cases into four categories. In RCAS1 I cases, fewer than 25% of tumor cells demonstrated immunoreactivity; in RCAS1 II, 25% to 50%
of the tumor cells exhibited staining; in RCAS1 III, 50% to 75% were positive; and in RCAS1 IV, more than 75% expressed the tumor antigen. RCAS1 II, III, and IV group tumors were considered to be high-expression samples, while RCAS1 I group tumors were low-expression samples [4] .
Results
Immunostaining for TTF-1 was not observed in either the gallbladder or lung of 42 primary lung adenocarcinomas [7] . As TTF-1 appears to be a highly specific marker of primary lung adenocarcinomas, TTF-1 expression should be examined for the differential diagnosis of primary and metastatic adenocarcinomas in the lung [8] . The expression profiles of these markers suggest that the lung tumor in our patient is not a primary tumor, but rather a metastasis derived from the primary gallbladder cancer.
A cDNA encoding the antigen recognized by the 22-1-1 antibody was designated the
receptor-binding cancer antigen expressed on SiSo cells (RCAS1). It was initially proposed
that the RCAS1 gene product is an integral membrane protein functioning as a ligand for a putative receptor present on normal peripheral lymphocytes, including T, B, and natural killer cells. Tumor cells may evade immune surveillance via expression of RCAS1, which may suppress clonal expansion and induce apoptosis in these immune cells possessing RCAS1 receptors [9] . In this study, positive RCAS1 staining was seen in the primary gallbladder tumor (RCAS1 III). We previously reported that strong RCAS1 expression by GBC significantly associated with venous involvement [4] , consistent with the hematogenous lung metastasis seen in this case. Interestingly, higher expression of RCAS1 was seen in the metastatic lung tumor (RCAS1 IV) than in the primary tumor. We observed a similar phenomenon in colorectal cancers with metastases to the liver. In eight of nine patients, RCAS1 expression was higher in the secondary liver tumors than in the primary tumors (data not shown). Cancer cells expressing RCAS1 may selectively travel to the lung, creating a metastatic focus in which all the cells express high levels of RCAS1. Our previous report suggested that high RCAS1 expression in GBC is an independent unfavorable prognostic factor. GBC expressing RCAS1 may have a higher potential to produce hematogenous metastases, leading to a poor prognosis and probably fatality. Some exceptions, including our patient, have been reported. Elias et al. reported long survival cases of resectable liver metastasis from GBC [10] in which RCAS1 was one of the important prognostic factors. Suzuki et al. resected lung metastasis from GBC by thoracospopic surgery [11] . There may be additional factors that may aid in the effective selection of operative cases with GBC metastasis.
In our case, no evidence of infiltration of CD8 + T cells was seen in primary GBC tumor. However, massive infiltration of CD8 + T cells was seen in metastatic lung tumor.
Tumor-infiltrating lymphocytes, particularly CD8 + T cells, may be of the hallmark of productive antitumor immunity and specifically recognize tumor cell epitopes [6] . If RCAS1 indirectly through a Tn modification [12] . Tn antigens, which are modulated by RCAS1, are generally involved in cell adhesion, invasion, and metastasis of cancer cells [13] . The immunosuppressive function of the Tn antigen, however, is unclear. Our immunohistochemical data could not identify a correlation between regions of RCAS1 expression and sites of CD8 + T cell infiltration. Thus, little evidence exists to suggest an interaction between RCAS1 and CD8 + T cells. The differences in CD8 + T cells status between a primary tumor of the gallbladder and a metastatic recurrence in the lung may be dependent on organ specificity, not RCAS1 expression. In the lung, the degree of CD8 + T cell infiltration into cancer cell nests or mesenchymal stroma is higher than that seen in the primary gall bladder tumor. While infiltrating CD8 + T cells are a positive prognostic independent factor in GBC, these cells do not appear to function as effectors in lung adenocarcinomas [14, 15] . The exceptional status of the cancer cells, which originated from gallbladder and were located within the lung, is unique to our patient. CD8 + T cells infiltrated and suppressed the metastatic cancer cells derived from the gall bladder present in the lung, such that multiple metastases or new metastatses may be exempted. In general, operative indication is not seen in metastatic foci in patients with GBC. Nevertheless, a long-term solitary metastasis which is infiltrated by CD8 + T cells can occasionally be effectively treated by surgical resection. It will be important in the future to determine the other prognostic factor predicting the efficacy of such treatment.
Conclusion
We observed the long-term disease-free survival of a patient with GBC, in whom both the primary GBC and a solitary metastatic lung tumor expressed high levels of RCAS1.
The results that resected metastasis is solitary and infiltrated by CD8 + T cells correspond with the present clinical history. (A) Macroscopically, a soft papillary tumor was found within the body of the gallbladder.
(B) In the right lung specimen, we observed a white nodular tumor. 
